Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
Top Cited Papers
Open Access
- 16 April 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 10 (8), 1210-1225
- https://doi.org/10.1158/2159-8290.cd-19-1355
Abstract
Sex-biased differences in myeloid-derived suppressor cell subsets mediated treatment responses in glioblastoma models; these differences were also observed in patients and were predictive of prognosis.Keywords
Other Versions
Funding Information
- NIH (R01NS109742)
- NIH (F32 CA243314)
- NIH (R01NS102669)
- Northwestern SPORE (P50CA221747)
- Case Comprehensive Cancer Center (T32 CA059366)
This publication has 51 references indexed in Scilit:
- GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-αCancer Research, 2013
- Gr‐1highCD11b+ Cells Suppress B Cell Differentiation and Lupus‐like Disease in Lupus‐Prone Male MiceArthritis & Rheumatism, 2013
- IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activationMolecular Cancer, 2012
- Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samplesTheory in Biosciences, 2012
- Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastomaNeuro-Oncology, 2011
- IL‐1β regulates a novel myeloid‐derived suppressor cell subset that impairs NK cell development and functionEuropean Journal of Immunology, 2010
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor ImmunityCancer Research, 2010
- Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing miceInternational Immunopharmacology, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapyCancer Immunology, Immunotherapy, 2008